Chronic fatigue syndrome: a review.

OBJECTIVE Chronic fatigue syndrome is an illness characterized by disabling fatigue of at least 6 months, accompanied by several other symptoms. This review summarizes the current state of knowledge about chronic fatigue syndrome. METHOD The case definition, prevalence, clinical presentation, evaluation, and prognosis of chronic fatigue syndrome are discussed. Research on the pathophysiology and treatment of chronic fatigue syndrome is reviewed. RESULTS Chronic fatigue syndrome is diagnosed on the basis of symptoms. Patients with chronic fatigue syndrome experience significant functional impairment. Pathophysiological abnormalities exist across many domains, suggesting that chronic fatigue syndrome is a heterogeneous condition of complex and multifactorial etiology. Evidence also is beginning to emerge that chronic fatigue syndrome may be familial. Although chronic fatigue syndrome has significant symptom overlap and comorbidity with psychiatric disorders, several lines of research suggest that the illness may be distinct from psychiatric disorders. Patients' perceptions, attributions, and coping skills, however, may help perpetuate the illness. Treatment for chronic fatigue syndrome is symptom-based and includes pharmacological and behavioral strategies. Cognitive behavior therapy and graded exercise can be effective in treating the fatigue and associated symptoms and disability. CONCLUSIONS Chronic fatigue syndrome is unlikely to be caused or maintained by a single agent. Findings to date suggest that physiological and psychological factors work together to predispose an individual to the illness and to precipitate and perpetuate the illness. The assessment and treatment of chronic fatigue syndrome should be multidimensional and tailored to the needs of the individual patient.

[1]  M. Fujieda,et al.  Defective killer cell activity in patients with chronic active Epstein-Barr virus infection. , 1988, Acta medica Okayama.

[2]  P. White,et al.  Strength and physiological response to exercise in patients with chronic fatigue syndrome , 2000, Journal of neurology, neurosurgery, and psychiatry.

[3]  Joseph A Maldjian,et al.  Brain MRI abnormalities exist in a subset of patients with chronic fatigue syndrome , 1999, Journal of the Neurological Sciences.

[4]  M. Demitrack Neuroendocrine correlates of chronic fatigue syndrome: a brief review. , 1997, Journal of psychiatric research.

[5]  Familial corticosteroid-binding globulin deficiency due to a novel null mutation: association with fatigue and relative hypotension. , 2001, The Journal of clinical endocrinology and metabolism.

[6]  P Wallace,et al.  Population based study of fatigue and psychological distress , 1994, BMJ.

[7]  J. DeLuca,et al.  Neuroimaging in chronic fatigue syndrome. , 1998, The American journal of medicine.

[8]  Eisenberg,et al.  Use of alternative treatments by chronic fatigue syndrome discordant twins. , 2000, Integrative medicine : integrating conventional and alternative medicine.

[9]  L. Krupp,et al.  A comparison of neuropsychiatric characteristics in chronic fatigue syndrome, multiple sclerosis, and major depression. , 1993, The Journal of neuropsychiatry and clinical neurosciences.

[10]  E. Cassem Depression and anxiety secondary to medical illness. , 1990, The Psychiatric clinics of North America.

[11]  D. Buchwald,et al.  High frequency of autoantibodies to insoluble cellular antigens in patients with chronic fatigue syndrome. , 1997, Arthritis and rheumatism.

[12]  K. E. Lucas,et al.  Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: a randomized controlled trial. , 2001, JAMA.

[13]  P. Sullivan,et al.  Genetic epidemiology of major depression: review and meta-analysis. , 2000, The American journal of psychiatry.

[14]  P. Manu,et al.  Alpha-Delta Sleep in Patients With a Chief Complaint of Chronic Fatigue , 1994, Southern medical journal.

[15]  V. Hesselbrock,et al.  Depression among patients with a chief complaint of chronic fatigue. , 1989, Journal of affective disorders.

[16]  A. Komaroff,et al.  High frequency of fibromyalgia in patients with chronic fatigue seen in a primary care practice. , 1990, Arthritis and rheumatism.

[17]  S. Wessely,et al.  Psychological symptoms, somatic symptoms, and psychiatric disorder in chronic fatigue and chronic fatigue syndrome: a prospective study in the primary care setting. , 1996, The American journal of psychiatry.

[18]  S. Wessely,et al.  Fatigue syndromes: a comparison of chronic "postviral" fatigue with neuromuscular and affective disorders. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[19]  Susan K. Johnson,et al.  Assessing Somatization Disorder in the Chronic Fatigue Syndrome , 1996, Psychosomatic medicine.

[20]  J. Levy,et al.  Immunologic abnormalities associated with chronic fatigue syndrome. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  T. Dinan,et al.  A preliminary study of dehydroepiandrosterone response to low-dose ACTH in chronic fatigue syndrome and in healthy subjects , 2000, Psychiatry Research.

[22]  I. Salit Precipitating factors for the chronic fatigue syndrome. , 1997, Journal of psychiatric research.

[23]  P. White The role of physical inactivity in the chronic fatigue syndrome. , 2000, Journal of psychosomatic research.

[24]  P. White The relationship between infection and fatigue. , 1997, Journal of psychosomatic research.

[25]  A. Mann,et al.  Chronic fatigue in primary care attenders , 1993, Psychological Medicine.

[26]  J. Tilles,et al.  alpha-Interferon treatment of patients with chronic fatigue syndrome. , 1996, Immunological investigations.

[27]  D. Buchwald,et al.  Chronic fatigue syndrome: an update. , 1998, Annual review of medicine.

[28]  R. Booth,et al.  Psychological influences on the perception of immune function , 1999, Psychological Medicine.

[29]  H. Mayberg,et al.  Monozygotic twins discordant for chronic fatigue syndrome: regional cerebral blood flow SPECT. , 2001, Radiology.

[30]  W. Mendelson,et al.  Sleep disturbance in chronic fatigue syndrome. , 1993, Journal of psychosomatic research.

[31]  I. Hickie,et al.  A double-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome. , 1990, The American journal of medicine.

[32]  D. Woodrow,et al.  Muscle fibre characteristics and lactate responses to exercise in chronic fatigue syndrome , 1998, Journal of neurology, neurosurgery, and psychiatry.

[33]  D. Buchwald,et al.  Autoantibodies to nuclear envelope antigens in chronic fatigue syndrome. , 1996, The Journal of clinical investigation.

[34]  D. Horrobin,et al.  Effect of high doses of essential fatty acids on the postviral fatigue syndrome , 1990, Acta neurologica Scandinavica.

[35]  H. Moldofsky,et al.  Sleep, Epstein-Barr virus infection, musculoskeletal pain, and depressive symptoms in chronic fatigue syndrome. , 1992, The Journal of rheumatology.

[36]  R. Kessler,et al.  Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. , 1994, Archives of general psychiatry.

[37]  G. Mcclearn,et al.  Genetics and behavioral medicine: risk factors for cardiovascular disease. , 1997, Behavioral medicine.

[38]  A. MacLeod,et al.  Causal attributions about common somatic sensations among frequent general practice attenders , 1996, Psychological Medicine.

[39]  C. Gottfries,et al.  Effects of staphylococcus toxoid vaccine on pain and fatigue in patients with fibromyalgia/chronic fatigue syndrome , 1998, European journal of pain.

[40]  T. Marrie,et al.  Cardiac function at rest and with exercise in the chronic fatigue syndrome. , 1989, Chest.

[41]  P. White,et al.  An open study of the efficacy and adverse effects of moclobemide in patients with the chronic fatigue syndrome , 1997, International clinical psychopharmacology.

[42]  S. Sisto,et al.  Metabolic and cardiovascular effects of a progressive exercise test in patients with chronic fatigue syndrome. , 1996, The American journal of medicine.

[43]  A. Komaroff,et al.  An examination of the working case definition of chronic fatigue syndrome. , 1996, The American journal of medicine.

[44]  P. Garfinkel,et al.  Chronic fatigue syndrome and depression: cause, effect, or covariate. , 1991, Reviews of infectious diseases.

[45]  A. Hackmann,et al.  Cognitive behaviour therapy for the chronic fatigue syndrome: a randomised controlled trial , 1996, BMJ.

[46]  P. Levine,et al.  A comparative review of systemic and neurological symptomatology in 12 outbreaks collectively described as chronic fatigue syndrome, epidemic neuromyasthenia, and myalgic encephalomyelitis. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[47]  G. Bleijenberg,et al.  Is physical deconditioning a perpetuating factor in chronic fatigue syndrome? A controlled study on maximal exercise performance and relations with fatigue, impairment and physical activity , 2001, Psychological Medicine.

[48]  I. Hickie,et al.  Immunologic and psychologic therapy for patients with chronic fatigue syndrome: a double-blind, placebo-controlled trial. , 1993, The American journal of medicine.

[49]  W. Blackwelder,et al.  Decreased bone mineral density during low dose glucocorticoid administration in a randomized, placebo controlled trial. , 2000, The Journal of rheumatology.

[50]  John R. Evans,et al.  Effects of Vitamin and Mineral Supplementation on Symptoms Associated with Chronic Fatigue Syndrome with Coxsackie B Antibodies , 1994 .

[51]  D. Greenberg,et al.  Neurasthenia in the 1980s: chronic mononucleosis, chronic fatigue syndrome, and anxiety and depressive disorders. , 1990, Psychosomatics.

[52]  Juliea Morris,et al.  Randomised, double-blind, placebo-controlled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome† , 1998, British Journal of Psychiatry.

[53]  R. Abs,et al.  Effect of growth hormone treatment in patients with chronic fatigue syndrome: a preliminary study. , 1998, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[54]  S. Wessely,et al.  Cognitive behavior therapy for chronic fatigue syndrome: a randomized controlled trial. , 1997, The American journal of psychiatry.

[55]  R. Kikinis,et al.  A Chronic Illness Characterized by Fatigue, Neurologic and Immunologic Disorders, and Active Human Herpesvirus Type 6 Infection , 1992, Annals of Internal Medicine.

[56]  I. Hickie,et al.  Complex genetic and environmental relationships between psychological distress, fatigue and immune functioning: a twin study , 1999, Psychological Medicine.

[57]  D. Cioffi BEYOND ATTENTIONAL STRATEGIES : A COGNITIVE-PERCEPTUAL MODEL OF SOMATIC INTERPRETATION , 1991 .

[58]  M. Antoni,et al.  Psychosocial correlates of illness burden in chronic fatigue syndrome. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[59]  W. Maixner,et al.  Sensitivity of patients with painful temporomandibular disorders to experimentally evoked pain: evidence for altered temporal summation of pain , 1998, Pain.

[60]  R. Perrin,et al.  An evaluation of the effectiveness of osteopathic treatment on symptoms associated with myalgic encephalomyelitis. A preliminary report. , 1998, Journal of medical engineering & technology.

[61]  S. Straus,et al.  Psychiatric diagnoses in patients who have chronic fatigue syndrome. , 1989, The Journal of clinical psychiatry.

[62]  B. Natelson,et al.  A controlled study of brain magnetic resonance imaging in patients with the chronic fatigue syndrome , 1993, Journal of the Neurological Sciences.

[63]  J. DeLuca,et al.  Depression in fatiguing illness: comparing patients with chronic fatigue syndrome, multiple sclerosis and depression. , 1996, Journal of affective disorders.

[64]  M. Campbell,et al.  Red blood cell magnesium and chronic fatigue syndrome , 1991, The Lancet.

[65]  G. Bleijenberg,et al.  The persistence of fatigue in chronic fatigue syndrome and multiple sclerosis: development of a model. , 1998, Journal of psychosomatic research.

[66]  P. Levine,et al.  Lessons from a pilot study of transfer factor in chronic fatigue syndrome , 1996, Biotherapy.

[67]  O. Bon,et al.  Sleep anomalies in the chronic fatigue syndrome. A comorbidity study. , 1997, Neuropsychobiology.

[68]  S. Wessely,et al.  Functional somatic syndromes: one or many? , 1999, The Lancet.

[69]  R. Bentall,et al.  A comparative psychiatric assessment of patients with chronic fatigue syndrome and muscle disease , 1991, Psychological Medicine.

[70]  I. Hickie,et al.  Unique genetic and environmental determinants of prolonged fatigue: a twin study , 1999, Psychological Medicine.

[71]  D. Buchwald,et al.  Coping strategies in twins with chronic fatigue and chronic fatigue syndrome. , 2000, Journal of psychosomatic research.

[72]  A. David,et al.  Neuroimaging in chronic fatigue syndrome. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[73]  D. Bates,et al.  SPECT imaging of the brain: comparison of findings in patients with chronic fatigue syndrome, AIDS dementia complex, and major unipolar depression. , 1994, AJR. American journal of roentgenology.

[74]  D. Bates,et al.  Prevalence of fatigue and chronic fatigue syndrome in a primary care practice. , 1993, Archives of internal medicine.

[75]  T. Findley,et al.  Randomized, double blind, controlled placebo-phase in trial of low dose phenelzine in the chronic fatigue syndrome , 1996, Psychopharmacology.

[76]  P. Manu,et al.  Chronic fatigue and chronic fatigue syndrome: clinical epidemiology and aetiological classification. , 1993, Ciba Foundation symposium.

[77]  Ian Hickie,et al.  Prevalence of chronic fatigue syndrome in an Australian population , 1990, The Medical journal of Australia.

[78]  Anne E. Figert,et al.  From Paralysis to Fatigue: A History of Psychosomatic Illness in the Modern Era. , 1993 .

[79]  A. Komaroff,et al.  NIH conference. Chronic fatigue syndrome research. Definition and medical outcome assessment. , 1992, Annals of internal medicine.

[80]  V. Seagroatt,et al.  Follow up of patients presenting with fatigue to an infectious diseases clinic. , 1992, BMJ.

[81]  R. Bentall,et al.  Randomised controlled trial of patient education to encourage graded exercise in chronic fatigue syndrome , 2001, BMJ : British Medical Journal.

[82]  F. Fouad-Tarazi,et al.  The connection between chronic fatigue syndrome and neurally mediated hypotension. , 1998, Cleveland Clinic journal of medicine.

[83]  P. Sullivan,et al.  A Twin Study of Chronic Fatigue , 2001, Psychosomatic medicine.

[84]  F A Jolesz,et al.  Detection of intracranial abnormalities in patients with chronic fatigue syndrome: comparison of MR imaging and SPECT. , 1994, AJR. American journal of roentgenology.

[85]  T. Field,et al.  Massage Therapy Effects on Depression and Somatic Symptoms in Chronic Fatigue Syndrome , 1997 .

[86]  M. Burnam,et al.  Somatization in the community. , 1987, Archives of general psychiatry.

[87]  W. Strober,et al.  Lymphocyte phenotype and function in the chronic fatigue syndrome , 2004, Journal of Clinical Immunology.

[88]  F. Zitman,et al.  A randomized, placebo-controlled, double-blind study of fluoxetine in Chronic Fatigue Syndrome , 1996 .

[89]  J. DeLuca,et al.  Neuropsychology of chronic fatigue syndrome: a critical review. , 1997, Journal of clinical and experimental neuropsychology.

[90]  B. Natelson,et al.  Impaired oxygen delivery to muscle in chronic fatigue syndrome. , 1999, Clinical science.

[91]  W. Weir,et al.  Interferon-alpha therapy for patients with chronic fatigue syndrome. , 1993, The Journal of infectious diseases.

[92]  M. Hotopf,et al.  The prognosis of chronic fatigue and chronic fatigue syndrome: a systematic review. , 1997, QJM : monthly journal of the Association of Physicians.

[93]  W. Weir,et al.  Coping and other predictors of outcome in chronic fatigue syndrome: a 1-year follow-up. , 1997, Journal of psychosomatic research.

[94]  M. Caligiuri,et al.  Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome. , 1987, Journal of immunology.

[95]  J. Bellanti,et al.  Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome. , 1999, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[96]  I. Hickie,et al.  Intravenous immunoglobulin is ineffective in the treatment of patients with chronic fatigue syndrome. , 1997, The American journal of medicine.

[97]  D. Smallwood,et al.  An epidemiologic study of fatigue with relevance for the chronic fatigue syndrome. , 1997, Journal of psychiatric research.

[98]  H. Calkins,et al.  The relationship between neurally mediated hypotension and the chronic fatigue syndrome. , 1995, JAMA.

[99]  M. Mckendrick,et al.  The role of essential fatty acids in chronic fatigue syndrome: A case‐controlled study of red‐cell membrane essential fatty acids (EFA) and a placebo‐controlled treatment study with high dose of EFA , 1999, Acta neurologica Scandinavica.

[100]  K. Kendler,et al.  A psychiatric dialogue on the mind-body problem. , 2001, The American journal of psychiatry.

[101]  D. Mccluskey,et al.  Aerobic work capacity in patients with chronic fatigue syndrome. , 1990, BMJ.

[102]  P. Manu,et al.  The low yield of physical examinations and laboratory investigations of patients with chronic fatigue. , 1990, The American journal of the medical sciences.

[103]  I. Hickie,et al.  The treatment of chronic fatigue syndrome: science and speculation. , 1994, The American journal of medicine.

[104]  E. Paykel,et al.  A family history study of chronic fatigue syndrome , 2001, Psychiatric genetics.

[105]  A. Hackmann,et al.  Chronic fatigue syndrome: a cognitive approach. , 1995, Behaviour research and therapy.

[106]  S. Wessely,et al.  Causal attributions for somatic sensations in patients with chronic fatigue syndrome and their partners , 2001, Psychological Medicine.

[107]  D. Buchwald,et al.  Chronic fatigue, chronic fatigue syndrome, and fibromyalgia. Disability and health-care use. , 1996, Medical care.

[108]  D. Stewart,et al.  Emotional Disorders Misdiagnosed as Physical Illness: Environmental Hypersensitivity, Candidiasis Hypersensitivity, and Chronic Fatigue Syndrome , 1990 .

[109]  N. Lurie,et al.  Double-blind placebo-controlled study of the efficacy of oral terfenadine in the treatment of chronic fatigue syndrome. , 1996, The Journal of allergy and clinical immunology.

[110]  J. Levy,et al.  Chronic fatigue syndrome: clinical condition associated with immune activation , 1991, The Lancet.

[111]  P. Keck,et al.  Comorbidity of fibromyalgia with medical and psychiatric disorders. , 1992, The American journal of medicine.

[112]  D. Buchwald,et al.  Comparison of patients with chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities. , 1994, Archives of internal medicine.

[113]  I. Hickie,et al.  The Psychiatric Status of Patients with the Chronic Fatigue Syndrome , 1990, British Journal of Psychiatry.

[114]  P. Behan,et al.  Changes in natural killer cell phenotype in patients with post‐viral fatigue syndrome , 1991, Clinical and experimental immunology.

[115]  L. Jason,et al.  Chronic Fatigue Syndrome, Fibromyalgia, and Multiple Chemical Sensitivities in a Community-Based Sample of Persons With Chronic Fatigue Syndrome-Like Symptoms , 2000, Psychosomatic medicine.

[116]  M. Power,et al.  Chronic fatigue in the community: ‘A question of attribution’ , 1996, Psychological Medicine.

[117]  R. Edwards,et al.  The metabolic consequences of reduced habitual activities in patients with muscle pain and disease. , 1988, Ergonomics.

[118]  C. Bisbal,et al.  A 37 kDa 2-5A binding protein as a potential biochemical marker for chronic fatigue syndrome. , 2000, The American journal of medicine.

[119]  D. Wood,et al.  Chronic fatigue in primary care. Prevalence, patient characteristics, and outcome. , 1988, JAMA.

[120]  S. Wessely,et al.  The prevalence and morbidity of chronic fatigue and chronic fatigue syndrome: a prospective primary care study. , 1997, American journal of public health.

[121]  R. Murray,et al.  Contrasting neuroendocrine responses in depression and chronic fatigue syndrome , 1995, Biological Psychiatry.

[122]  A. Thurm,et al.  Chronic fatigue syndrome in children and adolescents: a review. , 1998, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[123]  M. Chen The epidemiology of self-perceived fatigue among adults. , 1986, Preventive medicine.

[124]  L. Rucker,et al.  Liver extract-folic acid-cyanocobalamin vs placebo for chronic fatigue syndrome. , 1989, Archives of internal medicine.

[125]  P. Whiting,et al.  Interventions for the treatment and management of chronic fatigue syndrome: a systematic review. , 2001, JAMA.

[126]  A. Mann,et al.  Tired, weak, or in need of rest: fatigue among general practice attenders. , 1990, BMJ.

[127]  P. Tugwell,et al.  The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. , 1990, Arthritis and rheumatism.

[128]  M. Hotopf,et al.  Viruses, neurosis and fatigue. , 1994, Journal of psychosomatic research.

[129]  Renée R Taylor,et al.  Chronic Fatigue Syndrome , 2000, Evaluation & the health professions.

[130]  M. Speechley,et al.  Co-existence of chronic fatigue syndrome with fibromyalgia syndrome in the general population. A controlled study. , 2000, Scandinavian journal of rheumatology.

[131]  M. Fletcher,et al.  Immunologic abnormalities in chronic fatigue syndrome , 1990, Journal of clinical microbiology.

[132]  M. Sharpe,et al.  A Report–Chronic Fatigue Syndrome: Guidelines for Research , 1991, Journal of the Royal Society of Medicine.

[133]  R. Cluydts,et al.  Generalized anxiety disorder in chronic fatigue syndrome , 1997, Acta psychiatrica Scandinavica.

[134]  I. Hickie,et al.  Longitudinal study of outcome of chronic fatigue syndrome , 1994, BMJ.

[135]  T. Dinan,et al.  Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function. , 1991, The American journal of psychiatry.

[136]  M. Demitrack,et al.  Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. , 1991, The Journal of clinical endocrinology and metabolism.

[137]  W. Katon,et al.  Functional status in patients with chronic fatigue syndrome, other fatiguing illnesses, and healthy individuals. , 1996, The American journal of medicine.

[138]  P. Manu,et al.  The mental health of patients with a chief complaint of chronic fatigue. A prospective evaluation and follow-up. , 1988, Archives of internal medicine.

[139]  Susan K. Johnson,et al.  Neuropsychological impairments in chronic fatigue syndrome, multiple sclerosis, and depression. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[140]  D. Buchwald,et al.  Results of isoproterenol tilt table testing in monozygotic twins discordant for chronic fatigue syndrome. , 2000, Archives of internal medicine.

[141]  H. Calkins,et al.  Is neurally mediated hypotension an unrecognised cause of chronic fatigue? , 1995, The Lancet.

[142]  D. Buchwald,et al.  Significant Other Responses Are Associated With Fatigue and Functional Status Among Patients With Chronic Fatigue Syndrome , 2000, Psychosomatic medicine.

[143]  H. Pope,et al.  Affective spectrum disorder: does antidepressant response identify a family of disorders with a common pathophysiology? , 1990, The American journal of psychiatry.

[144]  L. Krupp,et al.  A comparison of cognitive behavioral treatment for chronic fatigue syndrome and primary depression. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[145]  S. Swan,et al.  A preliminary placebo-controlled crossover trial of fludrocortisone for chronic fatigue syndrome. , 1998, Archives of internal medicine.

[146]  Susan K. Johnson,et al.  Chronic fatigue syndrome: Reviewing the research findings , 1999, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

[147]  R. Goshorn Chronic Fatigue Syndrome: A Review for Clinicians , 1998, Seminars in neurology.

[148]  R. Schweitzer,et al.  Illness behaviour of patients with chronic fatigue syndrome. , 1994, Journal of psychosomatic research.

[149]  P. McGuffin,et al.  Is disabling fatigue in childhood influenced by genes? , 1999, Psychological Medicine.

[150]  P. Keck,et al.  Antidepressant treatment of fibromyalgia. A meta-analysis and review. , 2000, Psychosomatics.

[151]  M. Sharpe,et al.  Do patients with "pure" chronic fatigue syndrome (neurasthenia) have abnormal sleep? , 1997, Psychosomatic medicine.

[152]  G. Bleijenberg,et al.  The measurement of fatigue in patients with multiple sclerosis. A multidimensional comparison with patients with chronic fatigue syndrome and healthy subjects. , 1996, Archives of neurology.

[153]  P. Manu,et al.  Depression and somatization in the chronic fatigue syndrome. , 1991, The American journal of medicine.

[154]  K Y Fulcher,et al.  Randomised controlled trial of graded exercise in patients with the chronic fatigue syndrome , 1997, BMJ.

[155]  S. Kisely Treatments for Chronic Fatigue Syndrome and the Internet: A Systematic Survey of what Your Patients are Reading , 2002, The Australian and New Zealand journal of psychiatry.

[156]  M. Demitrack,et al.  Low-dose hydrocortisone for treatment of chronic fatigue syndrome: a randomized controlled trial. , 1998, JAMA.

[157]  K. Stefánsson,et al.  Trial of a Selective Acetylcholinesterase Inhibitor, Galanthamine Hydrobromide, in the Treatment of Chronic Fatigue Syndrome , 1996 .

[158]  S. Wessely,et al.  Clinical improvement in chronic fatigue syndrome is not associated with lymphocyte subsets of function or activation. , 1997, Clinical immunology and immunopathology.

[159]  W. Saxinger,et al.  Natural Killer Cell Activity in the Chronic Fatigue-Immune Dysfunction Syndrome , 1989 .

[160]  R. Cluydts,et al.  Neuropsychological functioning in chronic fatigue syndrome: a review , 2001, Acta psychiatrica Scandinavica.

[161]  K. Petrie,et al.  Cognitive distortions of somatic experiences: revision and validation of a measure. , 1997, Journal of psychosomatic research.

[162]  B. Natelson,et al.  Single-Blind, Placebo Phase-in Trial of Two Escalating Doses of Selegiline in the Chronic Fatigue Syndrome , 1998, Neuropsychobiology.

[163]  James F. Jones,et al.  Pain Perception in Chronic Fatigue Syndrome , 1998 .

[164]  S. Wessely,et al.  Chronic fatigue syndrome: a follow up study. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[165]  A. Fry,et al.  Fatigue in the chronic fatigue syndrome: a cognitive phenomenon? , 1996, Journal of psychosomatic research.

[166]  S. Wessely,et al.  Illness beliefs and treatment outcome in chronic fatigue syndrome. , 1998, Journal of psychosomatic research.

[167]  R. Dolan,et al.  Attributions and self-esteem in depression and chronic fatigue syndromes. , 1990, Journal of psychosomatic research.

[168]  Simon Wessely,et al.  Chronic Fatigue Syndrome , 1996, BMJ : British Medical Journal.

[169]  S. Wessely,et al.  Long-term outcome of cognitive behavior therapy versus relaxation therapy for chronic fatigue syndrome: a 5-year follow-up study. , 2001, The American journal of psychiatry.

[170]  W. Reeves,et al.  The epidemiology of chronic fatigue in San Francisco. , 1998, The American journal of medicine.

[171]  W. M. Goldberg,et al.  An evaluation of multidisciplinary intervention for chronic fatigue syndrome with long-term follow-up, and a comparison with untreated controls. , 1998, The American journal of medicine.

[172]  D. Oken Multiaxial Diagnosis and the Psychosomatic Model of Disease , 2000, Psychosomatic medicine.

[173]  N. Lurie,et al.  A controlled trial of intravenous immunoglobulin G in chronic fatigue syndrome. , 1990, The American journal of medicine.

[174]  D. T. Graham Health, Disease, and the Mind‐Body Problem: Linguistic Parallelism , 1967, Psychosomatic medicine.

[175]  M. Heijmans Coping and adaptive outcome in chronic fatigue syndrome: importance of illness cognitions. , 1998, Journal of psychosomatic research.

[176]  D. Buchwald,et al.  Sleep disorders in patients with chronic fatigue. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[177]  K. Petrie,et al.  Functioning in chronic fatigue syndrome: Do illness perceptions play a regulatory role? , 1996 .

[178]  A. Komaroff,et al.  Does the chronic fatigue syndrome involve the autonomic nervous system? , 1997, The American journal of medicine.

[179]  K. Rospenda,et al.  Chronic fatigue syndrome: have flawed assumptions been derived from treatment-based studies? , 1994, American journal of public health.

[180]  S. Lautenbacher,et al.  Multi-method assessment of experimental and clinical pain in patients with fibromyalgia , 1994, Pain.

[181]  M Freedman,et al.  Assessment of regional cerebral perfusion by 99Tcm-HMPAO SPECT in chronic fatigue syndrome. , 1992, Nuclear medicine communications.

[182]  G. Bleijenberg,et al.  Identifying physical activity patterns in chronic fatigue syndrome using actigraphic assessment. , 2000, Journal of psychosomatic research.

[183]  P. Morse,et al.  Hypochondriasis influences quality-of-life outcomes in patients with chronic fatigue. , 1996, Psychotherapy and psychosomatics.

[184]  B. Kendall,et al.  Cognitive Functioning and Magnetic Resonance Imaging in Chronic Fatigue , 1995, British Journal of Psychiatry.

[185]  D. Farrar,et al.  Chronic fatigue syndrome. 1: Etiology and pathogenesis. , 1995, Behavioral medicine.

[186]  A. Mann,et al.  Psychosocial risk factors for chronic fatigue and chronic fatigue syndrome following presumed viral illness: a case–control study , 1996, Psychological Medicine.

[187]  R. Kydd,et al.  Neuropsychological deficits in chronic fatigue syndrome: artifact or reality? , 1996, Journal of neurology, neurosurgery, and psychiatry.

[188]  Ian Hickie,et al.  The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study , 1994, Annals of Internal Medicine.

[189]  P. Garfinkel,et al.  The Neuropsychological Dimensions of Postinfectious Neuromyasthenia (Chronic Fatigue Syndrome): A Preliminary Report , 1990, International journal of psychiatry in medicine.

[190]  I. Hickie,et al.  A randomized, double-blind placebo-controlled trial of moclobemide in patients with chronic fatigue syndrome. , 2000, The Journal of clinical psychiatry.

[191]  P. Cowen,et al.  Abnormalities of sleep in patients with the chronic fatigue syndrome. , 1993, BMJ.

[192]  P. Dendale,et al.  Physical fatigability and exercise capacity in chronic fatigue syndrome: association with disability, somatization and psychopathology. , 1997, Journal of psychosomatic research.

[193]  W. Reeves,et al.  Surveillance for chronic fatigue syndrome--four U.S. cities, September 1989 through August 1993. , 1997, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[194]  D. Buchwald,et al.  Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder. , 2000, Archives of internal medicine.

[195]  S. Wessely,et al.  The neuroendocrinology of chronic fatigue syndrome and fibromyalgia , 2001, Psychological Medicine.

[196]  James M Barker,et al.  A case-control study to assess possible triggers and cofactors in chronic fatigue syndrome. , 1996, The American journal of medicine.

[197]  A. Komaroff,et al.  Chronic Fatigue and the Chronic Fatigue Syndrome: Prevalence in a Pacific Northwest Health Care System , 1995, Annals of Internal Medicine.

[198]  N. McGregor,et al.  Exercise capacity in chronic fatigue syndrome. , 2000, Archives of internal medicine.

[199]  P. Manu,et al.  Somatization disorder in patients with chronic fatigue. , 1989, Psychosomatics.